Arcturus Therapeutics Holdings Inc. Common Stock ARCT
$14.46
-4.77%
at last close
Financials (TTM)
- Revenue
- $29.37 million
- Net Income
- $-93,276,000
- Net Margin
- -317.62%
- Return on Equity
- -54.29%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.51
- Price / Sales
- 14.70
Over the trailing twelve months, Arcturus Therapeutics Holdings Inc. Common Stock generated revenue of $29.37 million and net income of $-93,276,000, a net margin of -317.62%.
At the last closing price of $14.46, ARCT trades at 14.70 times sales, with a market capitalization of $431.75 million.
Key Stats
- Last Close
- $14.46
- Market Cap
- $431.75 million
- 52-Week Range
- $5.50 – $24.17
- Average Volume
- 1.07 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.